It is a healthcare private limited company based in Delhi, Delhi, India, established in 2016.
2016 | Delhi, Delhi, India | ActiveUltramed Traexim Private Limited, a active private limited company, was established on 25 April 2016 in Delhi, Delhi, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U51909DL2016PTC298463. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹2.00 K .
It upholds a compliant status. Its leadership includes Ravi Bansal (Director), Sangitaa Bansal (Director), Rahul Bansal (Director). Past directors included Ravi Bansal, Vatsal Arya, Rahul Bansal. It holds ₹1.50 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1103, Klj Tower, Netaji Subhash Place, Pitampura, Delhi, Delhi, 110034.
U51909DL2016PTC298463
298463
25 April 2016
₹1.00 M
₹2.00 K
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Ultramed Traexim Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravi Bansal | Director | 16 Jul 2020 | Current |
| Sangitaa Bansal | Director | 25 Apr 2016 | Current |
| Rahul Bansal | Director | 30 Jan 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Apr 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Jan 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Oct 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ultramed Traexim Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 72.33% decrease. The company also saw a substantial fall in profitability, with a 59.84% decrease in profit. The company's net worth moved up by a moderate rise of 9%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Ultramed Traexim had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹15,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Mar 2021 | Hdfc Bank Limited | ₹1.00 Cr | Open |
| 07 Oct 2016 | Others | ₹5.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Ultramed Traexim, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ultramed Traexim, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ultramed Traexim's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Ultramed Traexim Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Ultramed Traexim Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 10.00 M with Charge ID 100435170 was registered on 08 Mar 2021. was documented.
The activity Ravi Bansal was appointed as a Director was appointed as a Director on 16 Jul 2020 & has been associated with this company since 5 years 4 months . was completed.
The activity Rahul Bansal was appointed as a Director was appointed as a Director on 30 Jan 2020 & has been associated with this company since 5 years 10 months . was completed.
Progress on A charge with Others amounted to Rs. 5.00 M with Charge ID 100061243 was registered on 07 Oct 2016. was documented.
The CIN of Ultramed Traexim Private Limited is U51909DL2016PTC298463.
Ultramed Traexim Private Limited is headquartered at 1103, Klj Tower, Netaji Subhash Place, Pitampura, Delhi, Delhi, 110034.
Ultramed Traexim Private Limited was incorporated on 25 April 2016.
The current directors of Ultramed Traexim Private Limited are
The primary industry of Ultramed Traexim Private Limited is Trade.
Ultramed Traexim Private Limited is unlisted.
The authorized capital of Ultramed Traexim Private Limited is ₹1.00 M, and the paid-up capital is ₹2.00 K .
The compliance status of Ultramed Traexim Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX